# Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

> **NCT00847210** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 36 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Dexlansoprazole MR
- **DRUG:** Dexlansoprazole MR

## Key facts

- **NCT ID:** NCT00847210
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847210, "Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00847210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*